Biora Therapeutics, Inc. (BIOR) Tops Q3 EPS by 5c

Biora Therapeutics, Inc. (NASDAQ: BIOR) reported Q3 EPS of ($0.03), $0.05 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $80 thousand versus the consensus estimate of $100 thousand.

For earnings history and earnings-related data on Biora Therapeutics, Inc. (BIOR) click here.

You May Also Be Interested In

• Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
• Oppenheimer Starts Teva Pharma (TEVA) at Outperform
• Activist Jana Partners calls for Six Flags sale - WSJ